Helus Pharma Appoints Michael Halstead as Chief Executive Officer

Written by

in

Former President of Intra-Cellular Therapies, Inc. was instrumental in building and scaling the company, which was subsequently acquired by Johnson & Johnson

Originally published via Source Article.